←
Neurofibromatosis Therapeutic Acceleration Program114 posts
Neurofibromatosis Therapeutic Acceleration Program avatar

Neurofibromatosis Therapeutic Acceleration Program

@ntapresearch

Accelerating the development of effective therapeutics for plexiform and cutaneous neurofibromas

◷ Joined May 2023▧ 51 Photos and videos
Children's Tumor Fdn avatar
⟳ Neurofibromatosis Therapeutic Acceleration Program retweeted
Children's Tumor Fdn@ChildrensTumor·Jun 27

Venture capital is in the room at the NF Conference. We've brought NF innovators and biotech investors together to pressure-test emerging programs on science, strategy, and the path to funding. Faster capital = faster treatments. #EndNF #NFConference

Post attachment
JHTV avatar
⟳ Neurofibromatosis Therapeutic Acceleration Program retweeted
JHTV@JHTechVentures·Jan 7

In case you missed it, our December newsletter is packed with highlights from 2025. - Check out exciting innovations - Learn about upcoming events and resources - Discover how we’re driving impact through entrepreneurship and tech commercialization buff.ly/KjiENf6

Post attachment
Neurofibromatosis Therapeutic Acceleration Program avatar
Neurofibromatosis Therapeutic Acceleration Program@ntapresearch·Jan 7

A powerful opportunity to advance innovative therapies and repurpose treatments — accelerating discoveries that can translate into real impact for patients. #EndNF #NFResearch #RareDisease #Innovation

🚨 Application for the 2025 Drug Discovery Initiative is OPEN! NF researchers, this is your chance to advance innovative therapies and repurposed treatments or validate new NF targets. Deadline: February 2, 2026 by 4 PM EST 🔗 Apply now: go.ctf.org/ddi #EndNF

Post attachment
Neurofibromatosis Therapeutic Acceleration Program avatar
Neurofibromatosis Therapeutic Acceleration Program@ntapresearch·25 Nov 2025

NTAP is proud to support @VasuLabUCSF and team's research published in @JCI_insight "Tumor heterogeneity underlies clinical outcome and MEK inhibitor response in somatic NF1-mutant glioblastoma" #EndNF #NFResearch

NF1 is frequently mutated in #glioblastoma, yet therapies targeting this alteration often fall short. @VasuLabUCSF & team @UCSF now show NF1 mutant glioblastomas exhibit prognostic signatures with distinct sensitivity to MEK inhibition: insight.jci.org/articles/vie…

Post attachment
Neurofibromatosis Therapeutic Acceleration Program avatar
Neurofibromatosis Therapeutic Acceleration Program@ntapresearch·24 Nov 2025

A powerful tribute to Dr. Verena Staedtke’s vision. Huge congratulations to Dr. Bai, @jblakel3, and the NTAP/JH/KKI teams for this exciting step forward. Grateful for the progress — and hopeful for what’s ahead. #EndNF #NFResearch

Honoring Verena Staedtke’s vision, @JohnsHopkins researchers, led by Renyuan Bai w/ support from Jaishri Blakeley at @ntapresearch, are advancing gene therapy for NF1. An AAV vector delivering neurofibromin shows promise + hope for patients. buff.ly/R4pRpoD

Post attachment
Neurofibromatosis Therapeutic Acceleration Program avatar
Neurofibromatosis Therapeutic Acceleration Program@ntapresearch·30 Sep 2025

1 day way! Join us tomorrow at 10AM for the Francis Collins Scholars Information session.

Are you an early-career clinician-scientist? Ready to make an impact on NF1 research? Join us for an information session on the Francis Collins Scholars Program. Wednesday, October 1, 2025 @ 10 AM EST 🔗 Register here: forms.office.com/r/nGqDFnN2B… #Research #EndNF #NF1

Post attachment
Children's Tumor Fdn avatar
⟳ Neurofibromatosis Therapeutic Acceleration Program retweeted
Children's Tumor Fdn@ChildrensTumor·15 Sep 2025

Fueling the next wave of NF research: Nearly $1.5M in Young Investigator Awards will drive cutting-edge science, smarter care & real solutions for NF1, NF2-SWN & SWN. Meet the early-career scientists shaping NF’s future: ctf.org/news/yia2025/

Post attachment
Neurofibromatosis Therapeutic Acceleration Program avatar
Neurofibromatosis Therapeutic Acceleration Program@ntapresearch·28 Jul 2025

🚨Updated Criteria! NTAP @HopkinsMedicine is funding early-career PhD (or equivalent) scientists focused on NF1 🧬 Learn more: NF1 Laboratory Scholars Program—mentorship, salary + project support! 🔗n-tap.org/who-we-are/news/ne… · LOI due: Oct 20, 2025 #EndNF